Archives

Initial commercial orders for the Apyx One console in South Korea are expected in Q4 2025 CLEARWATER FL, December 3, 2025 —Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx [...]

CLEARWATER FL, November 18, 2025 —Apyx® Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body [...]

CLEARWATER FL, November 17, 2025 —Apyx® Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body [...]

Initiated full U.S. commercial launch of AYON Body Contouring System™ (AYON) at end of Q3 2025, with demand for pre-orders exceeding expectations Submitted new 510(k) for AYON for device label [...]

CLEARWATER, FL — October 28, 2025 – Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology [...]

CLEARWATER, Fla. — October 28, 2025 – Apyx® Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology [...]

Initiated Nationwide Commercial Launch of AYON in September The Company is Hosting a Virtual Key Opinion Leader Event to Discuss the Commercial Launch of AYON on October 14, 2025  CLEARWATER, FL [...]